Prime Medicine
PRME
3.90
+0.40
+11.43%
Prime Medicine
US · PRME
#3501 by market cap
Listed 2022
3.90
+0.40
+11.43%
Live - 5344 symbols - heartbeat 457s ago
· 2026-10-08 09:09
Pre-market
3.85
-1.30%
After-hours
3.88
-0.42%
Overnight
3.94
+1.03%
- Market cap
- 707.37M
- P/E (TTM)i
- -3.71
- P/Bi
- 17.81
- EPSi
- -1.35
- Div yieldi
- 0.00%
- 52W posi
- 31%
Reader sentiment
Are you bullish or bearish on PRME?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 8 analysts
Buy
Avg price target
7.67 +96.7%
Price target rangecurrent 3.90
Low5.00
Avg7.67
High11.00
Buy 88%
Hold 13%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | LifeSci Capital | -- | BUY | 6.00 |
| 2026-10-01 | H.C. Wainwright | -- | BUY | 8.00 |
| 2026-09-25 | Oppenheimer | -- | BUY | 11.00 |
| 2026-09-24 | TD Cowen | -- | BUY | -- |
| 2026-09-24 | Chardan Capital | -- | BUY | 7.00 |
| 2026-09-24 | LifeSci Capital | -- | BUY | 6.00 |
| 2026-09-24 | BMO Capital | -- | BUY | 9.00 |
| 2026-08-25 | Chardan Capital | -- | BUY | 7.00 |
| 2026-08-19 | BMO Capital | -- | BUY | 9.00 |
| 2026-08-17 | LifeSci Capital | -- | BUY | 6.00 |
| 2026-08-10 | Morgan Stanley | -- | HOLD | -- |
| 2026-08-10 | H.C. Wainwright | -- | BUY | 8.00 |
| 2026-08-06 | LifeSci Capital | -- | BUY | 6.00 |
| 2026-08-06 | JonesTrading | -- | BUY | 5.00 |
| 2026-07-24 | LifeSci Capital | -- | BUY | 6.00 |
| 2026-07-11 | LifeSci Capital | -- | BUY | 6.00 |
| 2026-07-09 | H.C. Wainwright | -- | BUY | 8.00 |
| 2026-07-08 | LifeSci Capital | -- | BUY | 6.00 |
| 2026-07-08 | Morgan Stanley | -- | HOLD | -- |
| 2026-06-29 | H.C. Wainwright | -- | BUY | 8.00 |
| 2026-06-23 | LifeSci Capital | -- | BUY | 6.00 |
| 2026-06-18 | LifeSci Capital | -- | BUY | 6.00 |
| 2026-06-18 | Morgan Stanley | -- | HOLD | -- |
| 2026-05-13 | Morgan Stanley | -- | HOLD | -- |
| 2026-05-12 | Oppenheimer | -- | BUY | 11.00 |
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: H.C. Wainwright moved from Hold to Buy on 2026-06-29.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-29 | H.C. Wainwright | HOLD → BUY | 8.00 |
Quote time 2026-10-08 09:09:33 · For reference only, not investment advice and not tailored to your situation.